Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

The study is a Phase I/II, single-arm, open-label clinical trial, and its primary objective of phase I and phase II is to evaluate the safety and efficacy of U16 Injection in the treatment of relapsed or refractory NHL,respectively.

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: Oct 2, 2026Locations: 3
Eligibility criteria

Trial participants voluntarily sign the informed consent form and have good comp... [+12]

Concurrent other malignancies, except for malignancies with disease-free surviva... [+18]

Read more
Status: Recruiting

Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma

This is a single-arm, open-label clinical study evaluating the efficacy and safety of U01 (ssCART-19) in patients with relapsed or refractory B-cell lymphoma.

Participants needed: 30
Trial details
Phase: Phase 1Age: 2-75Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: May 6, 2026Locations: 1
Eligibility criteria

Voluntary written informed consent obtained from the participant (or legal guard... [+10]

Concurrent malignancy other than the study indication, except for carcinoma in s... [+11]

Read more
Status: Recruiting

Clinical Study of U32 in Patients With Acute Myeloid Leukemia

This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U32 injection in patients with acute myeloid leukemia.

Participants needed: 20
Trial details
Phase: Phase 1, Phase 2Age: 2-65Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: Jun 25, 2025Locations: 1
Eligibility criteria

Voluntarily sign the informed consent form and be expected to complete the follo... [+12]

Having other malignancies within 3 years prior to screening, with the exception... [+16]

Read more
Status: Recruiting

U87 CAR-T in Patients With Advanced Head and Neck Tumors

This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U87 injection solution in patients with advanced malignant head and neck tumors.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUpdated: Sep 26, 2024Locations: 1
Eligibility criteria

Subjects have provided informed consent, understanding the study's risks... [+9]

Inadequate washout period from prior anti-cancer treatments before leukapheresis... [+15]

Read more